DE BIASE, DARIO
 Distribuzione geografica
Continente #
AS - Asia 19.523
NA - Nord America 15.441
EU - Europa 11.635
SA - Sud America 1.047
AF - Africa 1.006
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 3
Totale 48.683
Nazione #
US - Stati Uniti d'America 15.131
VN - Vietnam 6.507
SG - Singapore 4.560
CN - Cina 4.334
IT - Italia 4.051
GB - Regno Unito 2.095
HK - Hong Kong 1.243
DE - Germania 1.225
SE - Svezia 939
BR - Brasile 781
IN - India 662
FR - Francia 661
KR - Corea 576
NL - Olanda 523
RU - Federazione Russa 461
BD - Bangladesh 411
IE - Irlanda 377
JP - Giappone 302
CI - Costa d'Avorio 290
FI - Finlandia 285
ZA - Sudafrica 266
CA - Canada 198
UA - Ucraina 161
SC - Seychelles 156
CH - Svizzera 147
TG - Togo 135
JO - Giordania 120
EE - Estonia 118
ID - Indonesia 118
PH - Filippine 117
AR - Argentina 102
BG - Bulgaria 102
AT - Austria 93
PK - Pakistan 87
PL - Polonia 81
TR - Turchia 76
MX - Messico 73
ES - Italia 69
IQ - Iraq 67
TH - Thailandia 67
TW - Taiwan 56
IR - Iran 46
EC - Ecuador 43
BE - Belgio 40
GR - Grecia 40
UZ - Uzbekistan 37
NG - Nigeria 27
LT - Lituania 26
AU - Australia 25
CZ - Repubblica Ceca 25
SA - Arabia Saudita 25
PY - Paraguay 24
CL - Cile 23
CO - Colombia 23
DZ - Algeria 21
RO - Romania 20
VE - Venezuela 20
MY - Malesia 17
KE - Kenya 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 14
EG - Egitto 14
MK - Macedonia 14
MA - Marocco 13
AZ - Azerbaigian 12
LB - Libano 12
PE - Perù 12
SN - Senegal 12
ET - Etiopia 10
HR - Croazia 10
JM - Giamaica 10
KZ - Kazakistan 10
AL - Albania 9
RS - Serbia 9
DK - Danimarca 8
MD - Moldavia 8
NP - Nepal 8
OM - Oman 8
PT - Portogallo 8
UY - Uruguay 7
DO - Repubblica Dominicana 6
NO - Norvegia 6
BO - Bolivia 5
CR - Costa Rica 5
GH - Ghana 5
SK - Slovacchia (Repubblica Slovacca) 5
GT - Guatemala 4
KG - Kirghizistan 4
LV - Lettonia 4
SI - Slovenia 4
UG - Uganda 4
CG - Congo 3
CY - Cipro 3
GE - Georgia 3
GY - Guiana 3
HU - Ungheria 3
ML - Mali 3
MT - Malta 3
NI - Nicaragua 3
PS - Palestinian Territory 3
Totale 48.624
Città #
Singapore 3.206
Ashburn 1.950
Southend 1.788
Ho Chi Minh City 1.718
Hanoi 1.446
Hong Kong 1.174
Hefei 1.171
Bologna 1.141
Fairfield 1.071
San Jose 877
Chandler 866
Santa Clara 681
Seoul 528
Seattle 515
Woodbridge 514
Houston 512
Wilmington 475
Beijing 470
Cambridge 414
Princeton 411
Dallas 388
Los Angeles 381
Dublin 373
Ann Arbor 365
Boardman 358
Dong Ket 299
Abidjan 290
Council Bluffs 283
Lauterbourg 277
Milan 275
New York 269
Tokyo 248
Da Nang 245
Helsinki 214
Haiphong 200
Berlin 146
Redmond 146
Nanjing 145
Westminster 145
Frankfurt am Main 139
Lomé 135
Turin 133
Buffalo 125
Padova 124
São Paulo 121
Amman 119
Bern 119
Johannesburg 116
Rimini 116
Rome 114
Redondo Beach 110
Bengaluru 109
Sofia 98
Jinan 92
Shanghai 90
Ha Long 87
Biên Hòa 85
Guangzhou 85
Florence 83
Hải Dương 83
Munich 79
Quận Bình Thạnh 78
Thái Nguyên 78
Can Tho 72
Saint Petersburg 71
San Diego 71
Jakarta 69
Chicago 67
Ninh Bình 67
Falls Church 66
Shenyang 64
Montreal 63
Changsha 62
Warsaw 61
Phoenix 59
Hyderabad 57
Amsterdam 56
Orem 56
Vũng Tàu 56
Atlanta 54
Jacksonville 54
London 54
Vienna 54
Bắc Ninh 53
Denver 52
Tianjin 52
Nanchang 50
Nuremberg 48
Naples 47
Des Moines 45
Modena 45
Medford 44
Toronto 44
Hebei 43
Zhengzhou 42
San Francisco 41
Falkenstein 40
Lappeenranta 40
Bremen 39
Hangzhou 39
Totale 30.490
Nome #
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 636
Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation. 594
MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis b-and c-related-hepatocellularcarcinoma 452
Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay 439
La malattia di Gaucher: una sindrome da iperattivazione dell’Hippo pathway? 388
The role of next-generation sequencing in the cytologic diagnosis of pancreatic lesions 381
A commentary on interstitial pneumonitis induced by docetaxel: Clinical cases and systematic review of the literature 380
Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel 346
Molecular biology of biliopancreatic lesions 339
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance 336
Gene polymorphism in tissue epidermal growth factor receptor (EGFR) influences clinical and histological vulnerability of carotid plaques 319
Spatial Cancer-Immune phenotypes predict shorter recurrence free survival in the NSMP molecular subtype of endometrial carcinoma 311
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 305
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers 302
Chalcones induce apoptosis, autophagy and reduce spreading in osteosarcoma 3D models 300
Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma 297
Correction to: Visani et al. mir-196b-5p and mir-200b-3p are differentially expressed in medulloblastomas of adults and children. diagnostics 2020, 10, 265 295
BRAF exon 15 mutations in papillary carcinoma and adjacent thyroid parenchyma: A search for the early molecular events associated with tumor development 294
Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review 286
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 275
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 269
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 267
A novel T137A SOD1 mutation in an Italian family with two subjects affected by amyotrophic lateral sclerosis 263
Homologous Recombination Deficiency (HRD) Status in Rare Histotypes of Ovarian Carcinomas: A Single-Center Experience 262
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 261
Analysis of MDM2 and TP53 genes in canine liposarcoma 260
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III 254
MicroRNA profiling reveals potential biomarkers for the early transformation of endometriosis towards endometriosis-correlated ovarian cancer 251
BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma 251
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 249
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option? 244
Does the site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification 241
What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 world health organization classification of female genital tumors 240
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 240
Next-generation technologies in predictive molecular pathology of lung cancers 239
High MYC levels favour multifocal carcinogenesis 238
Classification systems of endometrial cancer: A comparative study about old and new 234
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples 232
Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case–control validation study 231
Activity of the novel T137A SOD1 mutation in amyotrophic lateral sclerosis patients 231
T([20]) repeat in the 3'-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer 231
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors 231
HLA Class I Loss in Endometrial Carcinoma: Differences in the Immunosurveillance Pattern in Molecular Subtypes 227
Immunomagnetic enrichment coupled to PAX8/TP53 molecular pathology approach increases sensitivity in the detection of ovarian cancer cells in ascites 227
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. 223
n-3 LC-PUFAs modulate global gene expression in the left ventricle of spontaneously hypertensive rats 219
Evaluation of RNA from human trabecular bone and identification of stable reference genes 217
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 213
Matricellular proteins and survival in patients with pancreatic cancer: A systematic review 213
Adenoid Cystic Carcinoma of the Breast Associated With Invasive Duct Carcinoma: A Case Report 213
RET mutation and increased angiogenesis in medullary thyroid carcinomas 211
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 209
Human Cancer Cells Signal Their Competitive Fitness Through MYC Activity 207
Erratum to: Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 206
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience 204
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 204
Abstract 2603: What's more in serrated lesions: interobserver agreement and molecular features 203
Cutaneous Melanoma with "Paradoxical" p16 Hyper-expression: Molecular and Immunohistochemical Analysis of an Exceedingly Rare Entity with a Focus on Regulator Molecules of the Cell Cycle 201
A neurogenic model of adult brain cancer in Drosophila 200
Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review 200
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapy 200
Large Population Of Homogeneous Spheroids Models For Testing Toxicity And Diffusion Of Nanomaterials 199
Molecular analysis driven video-assisted thoracic surgery resections in bilateral synchronous lung cancers: From the test tube to the operatory room 199
Oncocytic carcinoma of the breast: frequency, morphology and follow-up 199
Oral sialadenoma papilliferum with kras mutation in a patient with linear nevus sebaceous syndrome 198
Failure of the PTEN/aPKC/Lgl Axis Primes Formation of Adult Brain Tumours in Drosophila 198
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes 197
Relevance of ARID1A Mutations in Endometrial Carcinomas 197
Brachial amyotrophic diplegia associated with the a140a superoxide dismutase 1 mutation. 196
aPKCz cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. 196
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer 196
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment 195
Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: A pilot study 195
Co-administration of propionate or protocatechuic acid does not affect dha-specific transcriptional effects on lipid metabolism in cultured hepatic cells 195
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 194
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 193
Ectopic Thyroid Tissue in the Adrenal Gland: Report of a Case. 193
Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number 192
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology 192
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power 190
Distinctive features of blood- and ascitic fluid-derived extracellular vesicles in ovarian cancer patients 189
High diagnostic adequacy and accuracy of the new 20G procore needle for EUS-guided tissue acquisition: Results of a large multicentre retrospective study 189
Patient outcomes following second surgery for recurrent glioblastoma 188
Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma? 188
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria 188
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 185
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study 183
The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy 183
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 182
Prevalence of Antigens/Antibodies Against Hepatitis B and C Viruses in A Cohort of Italian Patients with Pancreatic Adenocarcinoma Admitted to Two Hospital Wards in Italy: A Pivotal Retrospective Study 181
Concordance between RTOG and EORTC prognostic criteria in low-grade gliomas 179
MiR-196B-5P and miR-200B-3P are differentially expressed in medulloblastomas of adults and children 179
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6 179
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis 178
A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors 178
Importanza della modulazione dell’espressione genica nel meccanismo di protezione dei PUFA n-3 verso l’ipertrofia cardiaca 177
Team work and cytopathology molecular diagnosis of solid pancreatic lesions 177
Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results 176
Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients 175
Angiosarcoma and anaplastic carcinoma of the thyroid are two distinct entities: a morphologic, immunohistochemical, and genetic study 174
Totale 24.033
Categoria #
all - tutte 131.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021622 0 0 0 0 0 0 0 0 0 0 0 622
2021/20223.765 288 133 177 234 362 262 112 310 215 232 887 553
2022/20234.730 412 560 247 525 300 387 144 284 892 204 393 382
2023/20241.874 182 257 115 183 185 273 118 134 104 105 95 123
2024/20257.699 425 906 644 523 946 396 547 256 153 618 678 1.607
2025/202623.260 3.686 2.448 1.838 1.635 1.691 973 2.688 682 3.700 1.586 1.509 824
Totale 49.665